Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs VevaRX
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict61/ 100
Grade C · #341VevaRX
Publishes a real 36-state list, then prices tirzepatide only by the quarter and carries another company's copy inside its own legal pages.
Visit VevaRXThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 61/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. VevaRX still earns its place — a semaglutide buyer inside its 36 states who will not be caught by a quarterly charge.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results74
92
Real-world results74
97Price honesty58
97
Price honesty58
96Prescriber access50
96
Prescriber access50
88Formulary choice74
88
Formulary choice74
95Cancellation fairness50
95
Cancellation fairness50
93Member support56
93
Member support56
Price, coverage & features
| Metric | CoreAge Rx | VevaRX |
|---|---|---|
| Verdict Score | 94/100 | 61/100 |
| Grade | A | C |
| Semaglutide | $99/mo | $189/mo (the same page prints two other semaglutide figures, compounded) |
| Tirzepatide | $149/mo | Sold only as a 3-month prepay; no monthly rate is published |
| Coverage | All 50 states | 36 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
VevaRX
What we like
- Thirty-six states are enumerated by name in the FAQ rather than summarized as a nationwide claim
- Semaglutide has a genuine monthly rung alongside the three-month prepay
- The renewal cadence is stated on the product pages — every three months, cancel at any time
- Compounded status and the pharmacy relationship are disclosed in the Terms, including who to contact about the preparation
- Shipping and processing times are published as a real range rather than as a promise
The caveats
- Tirzepatide has no month-to-month option at all: the only way in is $467 charged once for three months, auto-renewing every quarter, and the per-month equivalent the page advertises does not divide correctly
- The semaglutide page prints three different figures for the same program and reconciles none of them
- Another brand's domain is named in VevaRX's own Terms as the site transactions are conducted on
- The contact page's FAQ is a different product's copy and gives instructions for mixing a powdered supplement under a question about how to take semaglutide or tirzepatide
- Three different return policies are live across the homepage FAQ, the contact page and the Terms, no pharmacy or clinician is named anywhere, and the only phone number is a text-only line published in the legal pages
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
A semaglutide buyer inside its 36 states who will not be caught by a quarterly charge.
Visit VevaRX Read the full VevaRX review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for VevaRX does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.